Press Release: Telix : Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
MELBOURNE, Australia and INDIANAPOLIS, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be...
Read full article »
Telix is an Australia-based biopharmaceutical firm that researches and develops molecularly targeted radiation therapeutic products for the treatment of cancer.
Read more